U.S. market Open. Closes in 4 hours 21 minutes

MEIP | MEI Pharma, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for MEIP we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is wealthy, Growth is bad and Health is very weak.

Valuation (41%)

Company Industry
P/E Ratio (TTM) 1.16 -23.05
PEG Ratio (TTM) -0.04 15.47
P/S Ratio (TTM) 0.31 49.46
P/B Ratio (TTM) 0.62 18.87
P/FCF Ratio (TTM) -0.41 -3.27
Price to 5YR AVG Earnings Ratio -0.54 -3.55
Price to 5YR AVG FCF Ratio -0.68 -9.37

Profitability (70%)

Company Industry
ROA (TTM) 42.95% -5.14%
ROE (TTM) 31.61% 16.69%
Net Profit Margin (TTM) 27.21% -1,583.93%
ROIC 5YR AVG -94.51% 15.15%

Growth (50%)

4QTR AVG 3YR AVG 5YR AVG
EPS 114.16% -36.42% 18.39%
Revenue 1,070.40% 178.65% 117.93%
Net Income 114.55% -66.61% -0.50%
Cash Flow -116.15% -9.79% -6.64%

Health (32%)

Company Industry
Current Ratio (TTM) 4.88 6.13
Quick Ratio (TTM) 4.88 5.85
D/E Ratio (TTM) N/A -15.81
Interest Coverage (TTM) N/A -1.57
Piotroski F-Score 5 5
Altman Z-Score N/A 14.12
LTL to 5YR AVG FCF N/A 0.17
Shares Outstanding Growth 5YR AVG 13.84% 123.44%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙